ホーム > 論文発表 Papers > 論文発表 2022年

論文発表 2022年

Original article

  1. Ukeba D, Yamada K, Suyama T, Lebl DR, Tsujimoto T, Nonoyama T, Sugino H, Iwasaki N, Watanabe M, Matsuzaki Y, Sudo H. Combination of ultra-purified stem cells with an in situ-forming bioresorbable gel enhances intervertebral disc regeneration.
    EBioMedicine
    , 76:103845, 2022
  2. Tsuda M, Horio R, Wang L, Takenami T, Moriya J, Suzuka J, Sugino H, Tanei Z, Tanino M, Tanaka S.. Novel rapid immunohistochemistry using an alternating current electric field identifies Rac and Cdc42 activation in human colon cancer FFPE tissues.
    Sci Rep
    , 12(1):1733.2022
  3. Ishio T, Kumar S, Shimono J, Daenthanasanmak A, Dubois S, Lin Y, Bryant B, Petrus MN, Bachy E, Huang DW, Yang Y, Green PL, Hasegawa H, Maeda M, Goto H, Endo T, Yokota T, Hatanaka KC, Hatanaka Y, Tanaka S., Matsuno Y, Yang Y, Hashino S, Teshima T, Waldmann TA, Staudt LM, Nakagawa M. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
    Blood.
    , 139, 1541-1556, 2022.
  4. Shimizu H, Enda K, Shimizu T, Ishida Y, Ishizu H, Ise K, Tanaka S., Iwasaki N. Machine Learning Algorithms: Prediction and Feature Selection for Clinical Refracture after Surgically Treated Fragility Fracture.
    J Clin Med.
    , 11(7):2022.
  5. Ishi Y, Yamaguchi S, Okamoto M, Sawaya R, Endo S, Motegi H, Terasaka S, Tanei ZI, Hatanaka KC, Tanaka S., Fujimura M. Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation.
    Brain Tumor Pathol.
    , 39(3):162-170.2022
  6. Tsuchida T, Wada T, Mizugaki A, Oda Y, Kayano K, Yamakawa K, Tanaka S.. Protocol for a Sepsis Model Utilizing Fecal Suspension in Mice: Fecal Suspension Intraperitoneal Injection Model.
    Front Med (Lausanne).
    , 9:765805.2022
  7. Yamasoba D, Kimura I, Nasser H, Morioka Y, Nao N, Ito J, Uriu K, Tsuda M, Zahradnik J, Shirakawa K, Suzuki R, Kishimoto M, Kosugi Y, Kobiyama K, Hara T, Toyoda M, Tanaka YL, Butlertanaka EP, Shimizu R, Ito H, Wang L, Oda Y, Orba Y, Sasaki M, Nagata K, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Kuramochi J, Seki M, Fujiki R, Kaneda A, Shimada T, Nakada TA, Sakao S, Suzuki T, Ueno T, Takaori-Kondo A, Ishii KJ, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Saito A, Irie T, Tanaka S., Matsuno K, Fukuhara T, Ikeda T, Sato K. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
    Cell
    , 185(12):2103-2115.e19. 2022
  8. Morikawa C, Sugiura K, Kondo K, Yamamoto Y, Kojima Y, Ozawa Y, Yoshioka H, Miura N, Piao J, Okada K, Hanamatsu H, Tsuda M, Tanaka S., Furukawa JI, Shinohara Y. Evaluation of the context of downstream N- and free N-glycomic alterations induced by swainsonine in HepG2 cells.
    Biochim Biophys Acta Gen Subj.
    , 1866(9):130168. 2022
  9. Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, Morioka Y, Nao N, Nasser H, Uriu K, Kosugi Y, Tsuda M, Orba Y, Sasaki M, Shimizu R, Kawabata R, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Ikeda T, Irie T, Matsuno K, Tanaka S., Fukuhara T, Sato K. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
    Nature
    , 603, 700-705, 2022.
  10. Kimura I, Yamasoba D, Tamura T, Nao N, Suzuki T, Oda Y, Mitoma S, Ito J, Nasser H, Zahradnik J, Uriu K, Fujita S, Kosugi Y, Wang L, Tsuda M, Kishimoto M, Ito H, Suzuki R, Shimizu R, Begum MM, Yoshimatsu K, Kimura KT, Sasaki J, Sasaki-Tabata K, Yamamoto Y, Nagamoto T, Kanamune J, Kobiyama K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Shirakawa K, Takaori-Kondo A, Kuramochi J, Schreiber G, Ishii KJ; Genotype to Phenotype Japan (G2P-Japan) Consortium, Hashiguchi T, Ikeda T, Saito A, Fukuhara T, Tanaka S., Matsuno K, Sato K. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants including BA.4 and BA.5.
    Cell
    , 185, 3992-4007, 2022.
  11. Saito, A., Tamura, T., Zahradnik, J., Deguchi, S., Tabata, K., Anraku, Y., Kimura, I., Ito, J., Yamasoba, D., Nasser, H., Toyoda, M., Nagata, K., Uriu, K., Kosugi, Y., Fujita, S., Shofa, M., Monira Begum, M., Shimizu, R., Oda, Y., Suzuki, R., Ito, H., Nao, N., Wang, L., Tsuda, M., Yoshimatsu, K., Kuramochi, J., Kita, S., Sasaki-Tabata, K., Fukuhara, H., Maenaka, K., Yamamoto, Y., Nagamoto, T., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Ueno, T., Schreiber, G., Takaori-Kondo, A., The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kotaro Shirakawa, Sawa, H., Irie, T., Hashiguchi, T., Takayama, K., Matsuno, K., Tanaka S.., Ikeda, T., Fukuhara, T., Sato, K. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
    Cell Host and Microbe
    , 30(11):1540-1555.e15. 2022
  12. Mu Q, Cui K, Wang ZJ, Matsuda T, Cui W, Kato H, Namiki S, Yamazaki T, Frauenlob M, Nonoyama T, Tsuda M, Tanaka S., Nakajima T, Gong JP. Force-triggered rapid microstructure growth on hydrogel surface for on-demand functions.
    Nat Commun.
    , 13, 6213, 2022.
  13. Mizugaki A, Wada T, Tsuchida T, Oda Y, Kayano K, Yamakawa K, Tanaka S. Neutrophil phenotypes implicated in the pathophysiology of post-traumatic sepsis.
    Front Med (Lausanne)
    , 9:982399. 2022
  14. Ferdous Z, Clément JE, Gong JP, Tanaka S, Komatsuzaki T, Tsuda M. Geometrical analysis identified morphological features of hydrogel-induced cancer stem cells in synovial sarcoma model cells.
    Biochem Biophys Res Commun.
    , 642:41-49. 2023

Case Report

  1. Konishi T, Takahashi Y, Kazui S, Yasui Y, Saiin K, Naito S, Takenaka, S, Mizuguchi Y, Tada A, Kobayashi Y, Omote K, Sato T, Kamiya K, Nagai T, Tanaka S., Anzai T Neoatherosclerosis with silent plaque rupture in a saphenous vein graft causing no re-flow phenomenon assessed by optical coherence tomography and histopathology
    Cardiol J
    , 9(4): 718-71
  2. Natsui H, Konishi T, Saiin K, Tamaki Y, Sato T, Takenaka S, Tada A, Mizuguchi Y, Kobayashi Y, Sato T, Kamada R, Kamiya K, Nagai T, Tanaka S., Anzai T. Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.
    Cardiol J.
    , 29(2):362-363.2022